GSK mRNA COVID-19 vaccine FDA approval by end of 2024? | Binary | | | 6 months ago | |
GSK COVID-19 Vaccine FDA Approval by End of 2024? | Binary | | | 6 months ago | |
GSK achieves €500 million revenue from mRNA vaccines by end of 2025? | Binary | | | 6 months ago | |
GSK mRNA flu vaccine launch by mid-2025? | Binary | | | 6 months ago | |
GSK Influenza Vaccine FDA Approval by End of 2024? | Binary | | | 6 months ago | |
GSK COVID-19 Vaccine Phase 3 Trials Start by Mid-2024? | Binary | | | 6 months ago | |
Total milestone payments from GSK to CureVac in 2024? | Categorical | | | 6 months ago | |
GSK makes first milestone payment to CureVac by mid-2024? | Binary | | | 6 months ago | |
GSK's mRNA COVID-19 vaccine Phase 3 trial starts by end of 2024? | Binary | | | 6 months ago | |
CureVac's next high-value mRNA project announcement by end of 2024? | Categorical | | | 6 months ago | |
CureVac completes 30% workforce reduction by end of Q1 2024? | Binary | | | 6 months ago | |
Outcome of GSK's mRNA flu vaccine Phase 2 trial by end of Q3 2024? | Categorical | | | 6 months ago | |
GSK mRNA COVID-19 vaccine market share by end of 2024? | Categorical | | | 6 months ago | |
Top revenue-generating mRNA vaccine for GSK in 2025? | Categorical | | | 6 months ago | |
GSK mRNA flu vaccine market share by end of 2025? | Categorical | | | 6 months ago | |
GSK New COVID-19 Vaccine Sales in 2025 | Categorical | | | 6 months ago | |
First Major Market to Approve GSK COVID-19 Vaccine by End of 2024 | Categorical | | | 6 months ago | |
GSK New Influenza Vaccine Sales in 2025 | Categorical | | | 6 months ago | |
